Yanmin Zhao
About
Yanmin Zhao is a scholar working on Hematology, Immunology and Molecular Biology.
According to data from OpenAlex, Yanmin Zhao has authored 164 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Hematology, 29 papers in Immunology and 25 papers in Molecular Biology. Recurrent topics in Yanmin Zhao's work include Hematopoietic Stem Cell Transplantation (55 papers), Acute Myeloid Leukemia Research (35 papers) and Acute Lymphoblastic Leukemia research (22 papers). Yanmin Zhao is often cited by papers focused on Hematopoietic Stem Cell Transplantation (55 papers), Acute Myeloid Leukemia Research (35 papers) and Acute Lymphoblastic Leukemia research (22 papers). Yanmin Zhao collaborates with scholars based in China, France and United States. Yanmin Zhao's co-authors include He Huang, Yi Luo, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jian Yu, Zhihua Zhou, Guoqing Wei, Wennan Zeng and Fei Gao and has published in prestigious journals such as Blood, PLoS ONE and Analytical Chemistry.
In The Last Decade
Yanmin Zhao
143 papers receiving 1.7k citations
Hit Papers
Peers
Yanmin Zhao
Luxuan Guo China
Lisha Ai China
Jürgen Brieger Germany
Gourab Bhattacharjee United States
Jan Šimák United States
Jelena Krstić Serbia
Alan Chan Netherlands
Roy Tarnuzzer United States
Luisa Campagnolo Italy
Kyrylo Tron Germany
Citations per year, relative to Yanmin Zhao Yanmin Zhao (= 1×)
peers
Luxuan Guo
Countries citing papers authored by Yanmin Zhao
Since
Specialization
Citations
This map shows the geographic impact of Yanmin Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanmin Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanmin Zhao more than expected).
Fields of papers citing papers by Yanmin Zhao
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yanmin Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanmin Zhao. The network helps show where Yanmin Zhao may publish in the future.
Co-authorship network of co-authors of Yanmin Zhao
This figure shows the co-authorship network connecting the top 25 collaborators of Yanmin Zhao. A scholar is included among the top collaborators of Yanmin Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanmin Zhao. Yanmin Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Xia, Yi, et al.. (2025). Upadacitinib, a selective JAK1 inhibitor, for the treatment of steroid refractory chronic graft‐versus‐host disease: A multicentre real‐world study. British Journal of Haematology. 207(1). 171–179.
2.
Shi, Ce, Xiangjun Zeng, Yi Luo, et al.. (2025). Machine learning-based prediction of G-CSF-induced hematopoietic stem cell mobilization outcomes in healthy volunteers. Bone Marrow Transplantation. 60(10). 1316–1324.
3.
Ma, Rui, Jianping Zhang, Jia Chen, et al.. (2024). Changing Donor Was Critical for the Successful Salvage Second Transplantation for Graft Failure after the First Allogeneic Stem Cell Transplantation: A Chinese Multicenter Retrospective Study. Blood. 144(Supplement 1). 2109–2109.
4.
Chen, Weihao, Yang Cao, Yi Luo, et al.. (2024). Validation and refinement of the 2022 European LeukaemiaNet genetic risk classification of acute myeloid leukaemia patients receiving allogeneic haematopoietic cell transplantation. Leukemia. 38(12). 2712–2716.
5.
Zhu, Panpan, Jimin Shi, Lizhen Liu, et al.. (2024). Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation. Clinical & Translational Immunology. 13(1). e1484–e1484.
6.
Jiang, Bingqian, Yanmin Zhao, Yi Luo, et al.. (2024). Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors. Cell Transplantation. 33. 4231283677–4231283677.
7.
Chen, Weihao, Jimin Shi, Yi Luo, et al.. (2024). Risk factors and long-term outcomes for human herpesvirus 6 encephalitis in the early period after allogeneic stem cell transplantation. Bone Marrow Transplantation. 59(10). 1387–1393.
8.
Zhu, Panpan, Xiaoyu Lai, Lizhen Liu, et al.. (2024). Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation. Journal of Translational Medicine. 22(1). 275–275.
9.
Dou, Liping, Yanmin Zhao, Xiaohui Zhang, et al.. (2023). Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis. Frontiers in Immunology. 14. 1091014–1091014.
10.
Shi, Jimin, Xiaoyu Lai, Yanmin Zhao, et al.. (2023). Survival and late mortality among patients who survived disease‐free for 2 years after stem cell transplantation. British Journal of Haematology. 202(3). 608–622.
11.
Lai, Xiaoyu, Jimin Shi, Lizhen Liu, et al.. (2023). A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation. Bone Marrow Transplantation. 58(7). 801–810.
12.
Gao, Fei, Jimin Shi, Yi Luo, et al.. (2023). Donor aKIR genes influence the risk of EBV and CMV reactivation after anti‐thymocyte globulin‐based haploidentical hematopoietic stem cell transplantation. HLA. 103(1). e15320–e15320.
13.
Liu, Lizhen, Xinyu Ji, Panpan Zhu, et al.. (2023). Double filtration plasmapheresis combined with rituximab for donor‐specific antibody desensitization in haploidentical haematopoietic stem cell transplantation. British Journal of Haematology. 203(5). 829–839.
14.
Liu, Yanru, Panpan Zhu, Jimin Shi, et al.. (2022). Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell Transplantation. Transplantation and Cellular Therapy. 28(6). 331.e1–331.e10.
15.
Huang, Changsheng, Yuanqiang Sun, Yanmin Zhao, et al.. (2022). Visual Monitoring of Nucleic Acid Dynamic Structures during Cellular Ferroptosis Using Rationally Designed Carbon Dots with Robust Anti-Interference Ability to Reactive Oxygen Species. ACS Applied Bio Materials. 5(6). 2703–2711.
16.
Feng, Jingjing, Xiaoxiao Xu, Xiaoqing Li, et al.. (2021). IL-17-producing γδT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1+CD11b+ myeloid-derived suppressor cells. Bone Marrow Transplantation. 56(10). 2389–2399.
17.
Ye, Yishan, Florent Malard, Jimin Shi, et al.. (2021). Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysis. Bone Marrow Transplantation. 56(10). 2567–2574.
18.
Lai, Xiaoyu, Jimin Shi, Yamin Tan, et al.. (2021). Effect of donor characteristics on T cell‐replete haploidentical stem cell transplantation over the last 10 years at a single institution. British Journal of Haematology. 196(5). 1225–1238.
19.
Zhang, Mingming, Haowen Xiao, Jimin Shi, et al.. (2021). Improved survival for young acute leukemia patients following a new donor hierarchy for allogeneic hematopoietic stem cell transplantation: A phase III randomized controlled study. American Journal of Hematology. 96(11). 1429–1440.
20.
Tan, Yamin, Jimin Shi, Yanmin Zhao, et al.. (2020). Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis. Bone Marrow Transplantation. 56(3). 664–672.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Luxuan Guo Breakdown of academic impact, for papers by Lisha Ai Breakdown of academic impact, for papers by Jürgen Brieger Breakdown of academic impact, for papers by Gourab Bhattacharjee Breakdown of academic impact, for papers by Jan Šimák Breakdown of academic impact, for papers by Jelena Krstić Breakdown of academic impact, for papers by Alan Chan Breakdown of academic impact, for papers by Roy Tarnuzzer Breakdown of academic impact, for papers by Luisa Campagnolo Breakdown of academic impact, for papers by Kyrylo Tron